S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
NASDAQ:CALC

CalciMedica (CALC) Stock Price, News & Analysis

$4.39
-0.05 (-1.13%)
(As of 04/15/2024 ET)
Today's Range
$4.29
$4.55
50-Day Range
$3.39
$5.80
52-Week Range
$1.75
$8.59
Volume
23,619 shs
Average Volume
21,733 shs
Market Capitalization
$47.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.67

CalciMedica MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
325.2% Upside
$18.67 Price Target
Short Interest
Healthy
0.79% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.44mentions of CalciMedica in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$3.42 M Bought Last Quarter
Proj. Earnings Growth
Growing
From ($2.04) to ($1.99) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.65 out of 5 stars

Medical Sector

449th out of 929 stocks

Pharmaceutical Preparations Industry

202nd out of 424 stocks

CALC stock logo

About CalciMedica Stock (NASDAQ:CALC)

CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.

CALC Stock Price History

CALC Stock News Headlines

Top 5 AI Stocks to Buy for 2024
5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.
Top 5 AI Stocks to Buy for 2024
5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.
CalciMedica GAAP EPS of -$0.82
See More Headlines
Receive CALC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/15/2024
Next Earnings (Estimated)
5/10/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CALC
Fax
N/A
Employees
14
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$18.67
High Stock Price Target
$22.00
Low Stock Price Target
$14.00
Potential Upside/Downside
+325.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-34,360,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.42 per share

Miscellaneous

Free Float
5,016,000
Market Cap
$47.15 million
Optionable
No Data
Beta
1.61
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Dr. A. Rachel Leheny Ph.D. (Age 61)
    CEO & Director
  • Mr. Eric W. Roberts (Age 60)
    Chief Business Officer & Vice Chairman of the Board
  • Mr. Michael J. Dunn MBA (Age 68)
    President & COO
  • Dr. Anjana Rao Ph.D.
    Co-Founder and Scientific Advisor
  • Dr. Patrick Hogan Ph.D.
    Co-Founder and Scientific Advisor
  • Dr. Stefan Feske M.D.
    Co-Founder and Scientific Advisor
  • Dr. Kenneth A. Stauderman Ph.D. (Age 71)
    Co-Founder & Chief Scientific Officer
  • Mr. Daniel E. Geffken M.B.A. (Age 67)
    Interim Chief Financial Officer
  • Cindy Reiedenberg
    Accountant
  • Mr. John M. Dunn J.D. (Age 72)
    General Counsel

CALC Stock Analysis - Frequently Asked Questions

Should I buy or sell CalciMedica stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CalciMedica in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CALC shares.
View CALC analyst ratings
or view top-rated stocks.

What is CalciMedica's stock price target for 2024?

3 brokers have issued 12 month price targets for CalciMedica's stock. Their CALC share price targets range from $14.00 to $22.00. On average, they anticipate the company's share price to reach $18.67 in the next year. This suggests a possible upside of 325.2% from the stock's current price.
View analysts price targets for CALC
or view top-rated stocks among Wall Street analysts.

How have CALC shares performed in 2024?

CalciMedica's stock was trading at $2.86 on January 1st, 2024. Since then, CALC stock has increased by 53.5% and is now trading at $4.39.
View the best growth stocks for 2024 here
.

Are investors shorting CalciMedica?

CalciMedica saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 37,200 shares, an increase of 318.0% from the March 15th total of 8,900 shares. Based on an average trading volume of 22,100 shares, the days-to-cover ratio is presently 1.7 days. Approximately 0.8% of the shares of the company are sold short.
View CalciMedica's Short Interest
.

When is CalciMedica's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our CALC earnings forecast
.

How do I buy shares of CalciMedica?

Shares of CALC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CALC) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners